Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
Factor-Xa inhibitors like edoxaban have been shown to have comparable or superior rates of stroke and systemic embolization prevention to warfarin while exhibiting lower clinically significant bleeding rates. The authors report a case of a man who presented with delayed, recurrent intracranial hemor...
Saved in:
Main Authors: | Walavan Sivakumar, Sarah T. Garber, Lauren E. Schrock, Paul A. House |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/691840 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diffuse Alveolar Hemorrhage Associated with Edoxaban Therapy
by: Kenichi Nitta, et al.
Published: (2016-01-01) -
Analysis of early results of edoxaban and warfarin in the treatment of deep vein thrombosis
by: Abdullah Guner, et al.
Published: (2024-03-01) -
Lead Fractures in Deep Brain Stimulation during Long-Term Follow-Up
by: Fernando Seijo Fernández, et al.
Published: (2010-01-01) -
Anesthesia for Pediatric Deep Brain Stimulation
by: Joseph Sebeo, et al.
Published: (2010-01-01) -
Minimizing hemorrhagic and perioperative complications in deep brain stimulation surgery in a series of 191 patients operated on over 4 years
by: Michał Sobstyl, et al.
Published: (2024-10-01)